Overweight and Obesity Clinical Trial
Official title:
Effect of Viscous Soluble Fibres on Body Weight Parameters: Review and Meta-analyses
Verified date | August 2017 |
Source | St. Michael's Hospital, Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Abstract:
Background: Obesity is a global pandemic affects all age groups and is independent risk
factors for most chronic diseases. Dietary intervention is an essential component of obesity
management. Dietary fibre supplements have the potential to facilitate weight reduction based
on their viscosity. Up to date, the evidence of effects of some fibres on weight is
inadequate, and literature provides insufficient information about the effects of the fibre
viscosity in weight management.
Objective: Two systematic reviews and meta-analyses of RCTs will be conducted to evaluate the
effectiveness of viscous fibres, (agar, alginate, b-glucan from oat and barley, guar gum,
glucomannan, pectin, PGX, psyllium), on body weight reduction.
Methods: Only randomised controlled trials are accepted. The trails must have one of the
selected fibres as a supplement, and the outcomes must have body weight, BMI, waist
circumference, or body fat percentage. Studies shorter than 4 weeks are excluded. Three
databases, (Medline, EMBASE, and Cochrane library), were searched through 04/03/2016.
Results: After removing duplicates, 82 studies will be reviewed in full. Significance: This
meta-analysis is the first meta-analysis that is based on fibre viscosity, and it will
quantify the effect of each fibre in improving weight loss. It will also direct future
research in the best direction to further explore this area.
Status | Active, not recruiting |
Enrollment | 1268 |
Est. completion date | November 2017 |
Est. primary completion date | November 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: 1. Must be a randomized controlled clinical trial with either a parallel or cross-over design 2. Must have a treatment period of at least 4 week. 3. Healthy children and adults, overweight and obese individuals or individuals with diabetes were all acceptable 4. Must have one of the selected viscous fibres, (agar, alginate, ß-glucan, guar gum, pectin, polyglycoplex(PGX), Psyllium, Xanthan), as a supplemented treatment. 5. Only ß-glucan sources from barley or oat were accepted The amount of barley product or barley ß-glucan must be reported or measured, or must be computable. ß-glucan was considered to be 4.75% in barley, and 3-5% in oat. 6. Must be appropriately controlled. 7. Must measure one of outcomes: body weight, BMI, waist circumference, or Body fat percentage. 8. These Anthropometry measures can be either primary or secondary outcomes. 9. Enough information must be provided to calculate the magnitude of effect, i.e. end of treatment measures and/or change from baseline measures 10. Ad lipitum diet only. Exclusion Criteria: 1. If the soluble fibre was not one of the selected viscous fibre or a combination. 2. supplement where these fibers could not be isolated each one alone. 3. If the study was insufficiently controlled, i.e. the control was another soluble fibre. 4. If the outcome measures did not include body weight, BMI, waist circumference, or Body fat percentage. 5. If the intervention was a diet with no supplemented fibre. 6. If the study provided insufficient information to calculate a magnitude of effect 7. If the study protocol maintains baseline weight. 8. Secondary information such as reviews, editorials, commentaries, were excluded 9. If the diet is hypo-caloric, energy restricted diet, or metabolically controlled diet. |
Country | Name | City | State |
---|---|---|---|
Canada | The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
St. Michael's Hospital, Toronto |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Body weight chang | unit of measure: Kg | in 4 weeks or more | |
Primary | BMI change | unit of measure: Kg/m2 | in 4 weeks or more | |
Primary | Waist circumference change | unit of measure: Cm | in 4 weeks or more | |
Primary | Body fat percentage change | unit of measure: % | in 4 weeks or more |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03994419 -
PErioperAtive CHildhood ObesitY
|
||
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03602001 -
Attentive Eating for Weight Loss
|
N/A | |
Recruiting |
NCT06269159 -
The Power of 24-hour: Co-designing Intervention Components
|
||
Completed |
NCT03377244 -
Healthy Body Healthy Souls in the Marshallese Population
|
N/A | |
Completed |
NCT02996864 -
Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II
|
N/A | |
Terminated |
NCT03914066 -
A Group-based Treatment of Overweight and Obesity in Primary Care
|
N/A | |
Completed |
NCT04647149 -
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
|
N/A | |
Completed |
NCT03685656 -
Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers
|
N/A | |
Completed |
NCT05051579 -
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
|
Phase 2 | |
Completed |
NCT04611477 -
Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals
|
N/A | |
Active, not recruiting |
NCT05330247 -
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
|
N/A | |
Completed |
NCT03599115 -
Effects of Inhibitory Control Training in Eating Behaviors
|
N/A | |
Recruiting |
NCT05938894 -
Train Your Brain - Executive Function
|
N/A | |
Recruiting |
NCT06094231 -
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
|
N/A | |
Recruiting |
NCT05987306 -
A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Completed |
NCT05055362 -
Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study
|
N/A | |
Completed |
NCT04520256 -
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
|
Phase 2/Phase 3 | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A |